| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/03/2003 | US20030125518 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 07/03/2003 | US20030125515 Endcapped genetically engineered human immunodeficiency viral polypeptides; viricides |
| 07/03/2003 | US20030125338 Compounds, compositions and methods for modulating beta-amyloid production |
| 07/03/2003 | US20030125292 Synergistic stimulating immunoglobulin A (IgA) production by administering a nucleic acid encapsulated with a lipid and at least one antigen |
| 07/03/2003 | US20030125278 Immunization of animals by topical applications of a salmonella-based vector |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus |
| 07/03/2003 | US20030124709 Preparation of a vaccine from enterotoxin and cytotoxins isolated from Salmonella sps. for protection against Salmonellosis in poultry, comprising: treating the said toxins with formalin in the predetermined ratio depending upon |
| 07/03/2003 | US20030124708 Modification of virus tropism and host range by viral genome shuffling |
| 07/03/2003 | US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents |
| 07/03/2003 | US20030124678 Interleukin-2 mutants with reduced toxicity |
| 07/03/2003 | US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA |
| 07/03/2003 | US20030124670 Analgesics; antinociceptive agents; antiinflammatory agents; antidiabbetic agents; diagnosing pain disorders |
| 07/03/2003 | US20030124658 Molecular display on multmeric protein scaffolds derived from the e2 component of the alphaketoacid dehydrogenase |
| 07/03/2003 | US20030124631 Monoclonal antibodies tnhat bind Pseudomona mucoid heteropolysaccharides; mucins; bactericides; cytotoxic agents |
| 07/03/2003 | US20030124621 Culturing/analyzing reaction of FC receptor-expressing cell line in the presence if immobilized antibody, separate, from Fab fragments; may be pretreated with cytokines or interefrons |
| 07/03/2003 | US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents |
| 07/03/2003 | US20030124614 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 07/03/2003 | US20030124613 Epitope testing using soluble HLA |
| 07/03/2003 | US20030124596 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 07/03/2003 | US20030124593 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124567 Use of a leptospire protein preventing and/or diagnosing and/or treating animal or human leptospirosis |
| 07/03/2003 | US20030124517 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof |
| 07/03/2003 | US20030124511 Method of production of purified hepatitis a virus particles and vaccine preparation |
| 07/03/2003 | US20030124510 Protein whose genome contains a region which is homologous to DNA restriction enzyme present in plasmid of escherichia coli; immunologically reactive; use in diagnostics and vaccines |
| 07/03/2003 | US20030124207 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/03/2003 | US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption |
| 07/03/2003 | US20030124192 Cross-linked hemicellulose as a vaccine adjuvant. |
| 07/03/2003 | US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix |
| 07/03/2003 | US20030124149 Bioactive absorbable microparticles as therapeutic vaccines |
| 07/03/2003 | US20030124148 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 07/03/2003 | US20030124145 Avian polynucleotide vaccine formula |
| 07/03/2003 | US20030124142 Immunomodulatory constructs and their uses |
| 07/03/2003 | US20030124141 Helicobacter polypeptides and corresponding polynucleotide molecules |
| 07/03/2003 | US20030124140 Ovarian tumor polypeptides, polynucleotides that encode them, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells |
| 07/03/2003 | US20030124139 Reduced aggregation and proteolytic breakdown; dissolution buffer comprising at least one amorphous excipient, at least one amorphous buffer, and at least one MenC immunogen |
| 07/03/2003 | US20030124138 Endogenous activating ligand which is a potentially important neuroregulator. |
| 07/03/2003 | US20030124137 For use in combatting a parasitic infestation of helminths; preferably of Fasciola or Dicrocoelium origin |
| 07/03/2003 | US20030124136 Immunotherapy for reversing immune suppression |
| 07/03/2003 | US20030124135 Recombinant intracellular pathogen vaccines and methods for use |
| 07/03/2003 | US20030124134 Pharmaceutical compositions and methods to vaccinate against candidiasis |
| 07/03/2003 | US20030124133 Polypeptide having a first domain with carbohydrate binding activity and a second domain with kinase activity; tumor immunotherapy |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124125 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10 |
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124119 Antibody is dissolved in a buffer solution containing as a buffer acetic acid, citric acid, phosphoric acid, and/or salts thereof and is a solution of pH 5 to 8. |
| 07/03/2003 | US20030124117 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124114 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 07/03/2003 | US20030124103 Tumor cells with increased immunogenicity and uses therefor |
| 07/03/2003 | US20030124097 Method to improve the safety of gene therapy |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124091 Administration of the factor with a vaccine to enhance immune response |
| 07/03/2003 | US20030124058 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 07/03/2003 | US20030124056 Carrier molecules |
| 07/03/2003 | CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | CA2476755A1 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/03/2003 | CA2471145A1 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/03/2003 | CA2471140A1 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | CA2470976A1 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 07/03/2003 | CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470316A1 Lyophilized preparation containing antibodies to the egf receptor |
| 07/03/2003 | CA2470178A1 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2469487A1 Mutated hiv tat |
| 07/03/2003 | CA2469132A1 Staphylococcus aureus exopolysaccharide and process |
| 07/03/2003 | CA2467099A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2462587A1 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | CA2436972A1 Immunogenic compositions comprising an antigen and a purified m protein from respiratory syncytial virus |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323823A2 Mammalian secretory peptide 9, antibodes against it and their use |
| 07/02/2003 | EP1323428A2 Avirulent Salmonella typhi microbes and uses thereof |
| 07/02/2003 | EP1323346A2 Receptor specific transepithelial transport of immunogens |
| 07/02/2003 | EP1322954A1 Method for treatment of insulin resistance in obesity and diabetes |
| 07/02/2003 | EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 07/02/2003 | EP1322768A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 07/02/2003 | EP1322763A2 Listeria inocua , genome and applications |
| 07/02/2003 | EP1322762A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 07/02/2003 | EP1322761A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 07/02/2003 | EP1322759A2 Potassium channel interactors and uses therefor |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322747A2 Improved formulations using heat shock/stress protein-peptide complexes |
| 07/02/2003 | EP1322669A1 Stabilisation of immunoglobulins at a low ph |
| 07/02/2003 | EP1322666A2 Hiv peptides from tat,rev and wef conserved regions and their application as e.gvacine compnents |
| 07/02/2003 | EP1322665A2 Hiv peptidesform concerved regions in gag p17 and 924 and their application in e.g vacines |
| 07/02/2003 | EP1322656A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322332A2 Compositions and methods for inhibition of hiv-1 infection |
| 07/02/2003 | EP1322330A2 Modulation of allergic response |
| 07/02/2003 | EP1322329A1 Split enveloped virus preparation |
| 07/02/2003 | EP1322328A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 07/02/2003 | EP1322327A1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 07/02/2003 | EP1322326A1 Innate immune system-directed vaccines |